This inventor holds 1 USPTO granted patent. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovations of Philip R Kastner
Introduction
Philip R Kastner is a notable inventor based in Loveland, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with adenosine receptors. His work has implications for medical treatments, especially in managing blood pressure.
Latest Patents
Kastner holds a patent for a compound known as (R)-2-[(phenylisopropyl)amino]adenosine. This compound exhibits a selectivity between the A-1 and A-2 adenosine receptors that is approximately two orders of magnitude greater than its diastereoisomer. This unique property makes it a valuable candidate for therapeutic applications aimed at lowering blood pressure.
Career Highlights
Throughout his career, Kastner has been associated with Merrell Dow Pharmaceuticals, where he has contributed to various research initiatives. His innovative approach to drug development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Kastner has worked alongside notable colleagues such as Norton P Peet and David R Borcherding. Their collaborative efforts have further advanced the research and development of new pharmaceutical compounds.
Conclusion
Philip R Kastner's contributions to the field of pharmaceuticals, particularly through his patent on (R)-2-[(phenylisopropyl)amino]adenosine, highlight his role as an influential inventor. His work continues to impact medical science and offers potential solutions for managing blood pressure.